{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:15:46Z","timestamp":1790399746308,"version":"4.1.0"},"reference-count":244,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.cpet.2009.12.008","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T06:22:12Z","timestamp":1275027732000},"page":"33-53","source":"Crossref","is-referenced-by-count":29,"title":["Amyloid PET Ligands for Dementia"],"prefix":"10.1016","volume":"5","author":[{"given":"Victor L.","family":"Villemagne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib1","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2006.03989.x","article-title":"Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics","volume":"97","author":"Masters","year":"2006","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1099-1166(199908)14:8<651::AID-GPS992>3.0.CO;2-B","article-title":"EUROCARE: a cross-national study of co-resident spouse carers for people with Alzheimer's disease: I\u2014factors associated with carer burden","volume":"14","author":"Schneider","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0011-5029(00)90028-2","article-title":"Part I. Epidemiology and public health impact of Alzheimer's disease","volume":"46","author":"Bennett","year":"2000","journal-title":"Dis Mon"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00019053-200018030-00002","article-title":"The epidemic of Alzheimer's disease. How can we manage the costs?","volume":"18","author":"Johnson","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"5594","key":"10.1016\/j.cpet.2009.12.008_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","article-title":"Alzheimer's disease is a synaptic failure","volume":"298","author":"Selkoe","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.cpet.2009.12.008_bib6","series-title":"Dementia","first-page":"393","article-title":"Neuropathology of Alzheimer's disease","author":"Masters","year":"2005"},{"key":"10.1016\/j.cpet.2009.12.008_bib7","series-title":"Neurodegenerative diseases: neurobiology, pathogenesis and therapeutics","first-page":"433","article-title":"The neuropathology of Alzheimer's disease in the year 2005","author":"Masters","year":"2005"},{"key":"10.1016\/j.cpet.2009.12.008_bib8","series-title":"Alzheimer disease: epidemiology, neuropathology, neurochemistry, and clinics","first-page":"61","article-title":"Morphology of Alzheimer disease and related disorders","author":"Jellinger","year":"1990"},{"key":"10.1016\/j.cpet.2009.12.008_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","article-title":"Neuropathology of Alzheimer's disease: a critical update","volume":"54","author":"Jellinger","year":"1998","journal-title":"J Neural Transm suppl"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1385\/JMN:19:3:289","article-title":"Tau neurofibrillary pathology and microtubule stability","volume":"19","author":"Michaelis","year":"2002","journal-title":"J Mol Neurosci"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib11","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque core protein in Alzheimer disease and down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib12","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1357-2725(99)00027-8","article-title":"Amyloid beta","volume":"31","author":"Cappai","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.cpet.2009.12.008_bib13","series-title":"Abeta peptide and Alzheimer's disease","first-page":"5","article-title":"The Abeta centric pathway of Alzheimer's disease","author":"Villemagne","year":"2006"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410380219","article-title":"Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy","volume":"38","author":"Greenberg","year":"1995","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archneur.62.5.721","article-title":"Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose F 18 positron emission tomographic study","volume":"62","author":"Mega","year":"2005","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of A\u03b2 amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"issue":"3 Pt 1","key":"10.1016\/j.cpet.2009.12.008_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7085","article-title":"The levels of soluble versus insoluble brain A\u03b2 distinguish Alzheimer's disease from normal and pathologic aging","volume":"158","author":"Wang","year":"1999","journal-title":"Exp Neurol"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib20","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.283.12.1571","article-title":"Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline","volume":"283","author":"Naslund","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3233\/JAD-2001-3305","article-title":"Amyloid Abeta levels in Alzheimer's disease\u2014a diagnostic tool and the key to understanding the natural history of Abeta?","volume":"3","author":"McLean","year":"2001","journal-title":"J Alzheimers Dis"},{"issue":"6880","key":"10.1016\/j.cpet.2009.12.008_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"issue":"Pt 5","key":"10.1016\/j.cpet.2009.12.008_bib23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1042\/BST0331087","article-title":"The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention","volume":"33","author":"Walsh","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.cpet.2009.12.008_bib24","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-2006-956752","article-title":"Mild cognitive impairment: current research and clinical implications","volume":"27","author":"Petersen","year":"2007","journal-title":"Semin Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib26","first-page":"93","article-title":"Mild cognitive impairment: transition between aging and Alzheimer's disease","volume":"15","author":"Petersen","year":"2000","journal-title":"Neurologia"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","article-title":"Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American academy of neurology","volume":"56","author":"Petersen","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0733-8619(05)70226-7","article-title":"Aging, mild cognitive impairment, and Alzheimer's disease","volume":"18","author":"Petersen","year":"2000","journal-title":"Neurol Clin"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch Neurol"},{"issue":"Pt 11","key":"10.1016\/j.cpet.2009.12.008_bib30","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awl251","article-title":"Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway","volume":"129","author":"Masters","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2009.12.008_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/197140090601900406","article-title":"La Lunga Attesa: towards a molecular approach to neuroimaging and therapeutics in Alzheimer's disease","volume":"19","author":"Villemagne","year":"2006","journal-title":"Neuroradiol J"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib32","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000017235","article-title":"Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease","volume":"11","author":"Armstrong","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.cpet.2009.12.008_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","article-title":"Abeta deposition is associated with enhanced cortical a-synuclein lesions in Lewy body diseases","volume":"26","author":"Pletnikova","year":"2005","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib35","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/jnen\/64.5.420","article-title":"Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias","volume":"64","author":"Mott","year":"2005","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"2\u20133","key":"10.1016\/j.cpet.2009.12.008_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbadis.2004.06.020","article-title":"Tau protein as\u00a0a differential biomarker of tauopathies","volume":"1739","author":"Sergeant","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00401-002-0529-5","article-title":"Consensus neuropathological diagnosis of common dementia syndromes: testing and standardising the use of multiple diagnostic criteria","volume":"104","author":"Halliday","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib39","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archneur.64.10.1388","article-title":"TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis","volume":"64","author":"Neumann","year":"2007","journal-title":"Arch Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1017\/S1041610297004900","article-title":"Contribution of structural neuroimaging to the early diagnosis of Alzheimer's disease","volume":"9","author":"de Leon","year":"1997","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0197-4580(01)00271-8","article-title":"MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease","volume":"22","author":"Dickerson","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib42","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I","article-title":"Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease","volume":"47","author":"Killiany","year":"2000","journal-title":"Ann Neurol"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib43","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1212\/WNL.54.9.1760","article-title":"Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD","volume":"54","author":"Xu","year":"2000","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cpet.2009.12.008_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.nucmedbio.2007.06.015","article-title":"Impact of amyloid imaging on drug development in Alzheimer's disease","volume":"34","author":"Mathis","year":"2007","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12035-008-8019-y","article-title":"The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias","volume":"38","author":"Villemagne","year":"2008","journal-title":"Mol Neurobiol"},{"issue":"47","key":"10.1016\/j.cpet.2009.12.008_bib46","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","article-title":"Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease","volume":"25","author":"Okamura","year":"2005","journal-title":"J Neurosci"},{"issue":"18","key":"10.1016\/j.cpet.2009.12.008_bib47","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1021\/ja9008369","article-title":"Fluorescent BODIPY-based Zn(II) complex as a molecular probe for selective detection of neurofibrillary tangles in the brains of Alzheimer's disease patients","volume":"131","author":"Ojida","year":"2009","journal-title":"J Am Chem Soc"},{"issue":"4 Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib48","doi-asserted-by":"crossref","first-page":"P209","DOI":"10.1016\/j.jalz.2009.04.122","article-title":"In-vivo optical and PET detections of fibrillar tau lesions in a mouse model of tauopathies [abstract]","volume":"55","author":"Maruyama","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00234-003-1034-9","article-title":"In vivo amyloid imaging in Alzheimer's disease","volume":"46","author":"Sair","year":"2004","journal-title":"Neuroradiology"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jocn.2004.03.011","article-title":"Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease","volume":"12","author":"Villemagne","year":"2005","journal-title":"J\u00a0Clin Neurosci"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archneur.62.2.196","article-title":"Imaging technology for neurodegenerative diseases: progress toward detection of specific pathologies","volume":"62","author":"Mathis","year":"2005","journal-title":"Arch Neurol"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib52","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","article-title":"Sequence of Abeta-protein deposition in the human medial temporal lobe","volume":"59","author":"Thal","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0197-4580(00)00237-2","article-title":"Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34","volume":"22","author":"Link","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0197-4580(94)90050-7","article-title":"Development of small molecule probes for the beta-amyloid protein of Alzheimer's disease","volume":"15","author":"Klunk","year":"1994","journal-title":"Neurobiol Aging"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib55","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00004647-200209000-00001","article-title":"Imaging amyloid-beta deposits in vivo","volume":"22","author":"Bacskai","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jnen\/61.9.797","article-title":"Imaging A\u03b2 plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative","volume":"61","author":"Klunk","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"21","key":"10.1016\/j.cpet.2009.12.008_bib57","doi-asserted-by":"crossref","first-page":"12462","DOI":"10.1073\/pnas.2034101100","article-title":"Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice","volume":"100","author":"Bacskai","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1016\/j.cpet.2009.12.008_bib58","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","article-title":"Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents","volume":"46","author":"Mathis","year":"2003","journal-title":"J Med Chem"},{"issue":"1\u20132","key":"10.1016\/j.cpet.2009.12.008_bib59","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12031-002-0004-8","article-title":"Synthesis and evaluation of 2-(3\u2032-iodo-4\u2032-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease","volume":"19","author":"Wang","year":"2002","journal-title":"J Mol Neurosci"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib60","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JMN:20:3:255","article-title":"Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives","volume":"20","author":"Wang","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.cpet.2009.12.008_bib61","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1126\/science.297.5582.752b","article-title":"Long-awaited technique spots Alzheimer's toxin","volume":"297","author":"Helmuth","year":"2002","journal-title":"Science"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib62","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/jlcr.2580440110","article-title":"Lipophilic 11C-labelled thioflavin-T analogues for imaging amyloid plaques in Alzheimer's disease","volume":"44","author":"Mathis","year":"2001","journal-title":"J. Labelled Cpd Radiopharm"},{"issue":"13","key":"10.1016\/j.cpet.2009.12.008_bib63","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","article-title":"Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain","volume":"69","author":"Klunk","year":"2001","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib64","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","article-title":"The binding of 2-(4\u2032-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component","volume":"23","author":"Klunk","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0960-894X(01)00734-X","article-title":"A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain","volume":"12","author":"Mathis","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib66","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/jm010045q","article-title":"Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates","volume":"44","author":"Zhuang","year":"2001","journal-title":"J Med Chem"},{"issue":"50","key":"10.1016\/j.cpet.2009.12.008_bib67","doi-asserted-by":"crossref","first-page":"12740","DOI":"10.1021\/ja0167147","article-title":"Novel stilbenes as probes for amyloid plaques","volume":"123","author":"Kung","year":"2001","journal-title":"J Am Chem Soc"},{"issue":"13","key":"10.1016\/j.cpet.2009.12.008_bib68","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1073\/pnas.97.13.7609","article-title":"In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease","volume":"97","author":"Skovronsky","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.cpet.2009.12.008_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12031-002-0003-9","article-title":"Radioiodinated styrylbenzene derivatives as potential SPECT imaging agents for amyloid plaque detection in Alzheimer's disease","volume":"19","author":"Kung","year":"2002","journal-title":"J Mol Neurosci"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib70","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0969-8051(01)00264-5","article-title":"IBOX(2-(4\u2032-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain","volume":"28","author":"Zhuang","year":"2001","journal-title":"Nucl Med Biol"},{"issue":"14","key":"10.1016\/j.cpet.2009.12.008_bib71","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1021\/jm010161t","article-title":"Isomerization of (Z, Z) to (E, E)1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene in strong base: probes for amyloid plaques in the brain","volume":"44","author":"Lee","year":"2001","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib72","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9440(10)61769-5","article-title":"The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse \u03b2-pleated sheet structures in postmortem human neurodegenerative disease brains","volume":"159","author":"Schmidt","year":"2001","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/jm020351j","article-title":"Structure-activity relationship of imidazo[1,2-a]pyridines as ligands for detecting beta-amyloid plaques in the brain","volume":"46","author":"Zhuang","year":"2003","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib74","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0006-8993(02)03436-4","article-title":"IMPY: an improved thioflavin-T derivative for in vivo labeling of beta-amyloid plaques","volume":"956","author":"Kung","year":"2002","journal-title":"Brain Res Bull"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib75","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0969-8051(02)00326-8","article-title":"Benzofuran derivatives as Abeta-aggregate-specific imaging agents for Alzheimer's disease","volume":"29","author":"Ono","year":"2002","journal-title":"Nucl Med Biol"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0969-8051(03)00049-0","article-title":"11C-labeled stilbene derivatives as Abeta-aggregate-specific PET imaging agents for Alzheimer's disease","volume":"30","author":"Ono","year":"2003","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/JMN:20:1:15","article-title":"Detection of amyloid plaques by radioligands for Abeta40 and Abeta42: potential imaging agents in Alzheimer's patients","volume":"20","author":"Kung","year":"2003","journal-title":"J Mol Neurosci"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1385\/JMN:20:3:249","article-title":"Characterization of radioiodinated ligand binding to amyloid beta plaques","volume":"20","author":"Kung","year":"2003","journal-title":"J Mol Neurosci"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0969-8051(03)00050-7","article-title":"Dimethylamino-fluorenes: ligands for detecting beta-amyloid plaques in the brain","volume":"30","author":"Lee","year":"2003","journal-title":"Nucl Med Biol"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib80","first-page":"2184","article-title":"Development of a monoclonal antibody specific for b\/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy","volume":"33","author":"Majocha","year":"1992","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib81","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005072-199407000-00009","article-title":"Labelling of cerebral amyloid in vivo with a monoclonal antibody","volume":"53","author":"Walker","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib82","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0197-4580(02)00121-5","article-title":"Related Amyloid binding ligands as Alzheimer's disease therapies","volume":"23","author":"Lee","year":"2002","journal-title":"Neurobiol Aging"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib83","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/bc010066z","article-title":"Noninvasive imaging of peripherally injected Alzheimer's disease type synthetic A beta amyloid in vivo","volume":"13","author":"Marshall","year":"2002","journal-title":"Bioconjug Chem"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib84","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1021\/bc9901393","article-title":"Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections","volume":"11","author":"Kurihara","year":"2000","journal-title":"Bioconjug Chem"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib85","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04591.x","article-title":"In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques","volume":"102","author":"Poduslo","year":"2007","journal-title":"J Neurochem"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib86","first-page":"1044","article-title":"Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice","volume":"43","author":"Shi","year":"2002","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib88","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib89","first-page":"584","article-title":"In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET","volume":"12","author":"Verhoeff","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib90","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.clpt.2006.05.007","article-title":"A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease","volume":"80","author":"Bauer","year":"2006","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib91","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2967\/jnumed.106.037556","article-title":"2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients","volume":"48","author":"Kudo","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2009.12.008_bib92","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00259-009-1182-1","article-title":"Detection of amyloid in Alzheimer's disease with positron emission tomography using [(11)C]AZD2184","volume":"36","author":"Nyberg","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","article-title":"Imaging of amyloid beta in Alzheimer's disease with (18)F-BAY94-9172, a novel PET tracer: proof of mechanism","volume":"7","author":"Rowe","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cpet.2009.12.008_bib94","doi-asserted-by":"crossref","first-page":"7090","DOI":"10.1021\/jm900871v","article-title":"Synthesis and evaluation of (18)F-labeled 2-phenylbenzothiazoles as positron emission tomography imaging agents for amyloid plaques in Alzheimer's disease","volume":"52","author":"Serdons","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.cpet.2009.12.008_bib95","first-page":"214P","article-title":"In vivo imaging of amyloid deposition in Alzheimer's disease using the novel radioligand [F-18]AV-45 [abstract]","volume":"49","author":"Wong","year":"2008","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib96","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1474-9726.2006.00196.x","article-title":"Radioiodinated clioquinol as a biomarker for beta-amyloid:Zn complexes in Alzheimer's disease","volume":"5","author":"Opazo","year":"2006","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib97","first-page":"748","article-title":"Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease","volume":"47","author":"Newberg","year":"2006","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib98","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1471-4159.2007.04972.x","article-title":"Congo red and thioflavin-T analogs detect Abeta oligomers","volume":"104","author":"Maezawa","year":"2008","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib99","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ana.21321","article-title":"A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia","volume":"63","author":"Tomiyama","year":"2008","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.nucmedbio.2007.10.005","article-title":"IMPY, a potential beta-amyloid imaging probe for detection of prion deposits in scrapie-infected mice","volume":"35","author":"Song","year":"2008","journal-title":"Nucl Med Biol"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib101","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.bmcl.2009.02.096","article-title":"Synthesis and beta-amyloid binding properties of rhenium 2-phenylbenzothiazoles","volume":"19","author":"Lin","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib102","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/jm070025+","article-title":"Novel styrylpyridines as probes for SPECT imaging of amyloid plaques","volume":"50","author":"Qu","year":"2007","journal-title":"J Med Chem"},{"issue":"13","key":"10.1016\/j.cpet.2009.12.008_bib103","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1016\/j.bmcl.2007.04.062","article-title":"Radioiodinated aza-diphenylacetylenes as potential SPECT imaging agents for beta-amyloid plaque detection","volume":"17","author":"Qu","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"22","key":"10.1016\/j.cpet.2009.12.008_bib104","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.bmcl.2007.09.055","article-title":"Synthesis and evaluation of a (99m)Tc-BAT-phenylbenzothiazole conjugate as a potential in vivo tracer for visualization of amyloid beta","volume":"17","author":"Serdons","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"10.1016\/j.cpet.2009.12.008_bib105","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B","volume":"25","author":"Price","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib106","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1074\/jbc.M412056200","article-title":"Evidence for the presence of three distinct binding sites for the thioflavin T class of Alzheimer's disease PET imaging agents on beta-amyloid peptide fibrils","volume":"280","author":"Lockhart","year":"2005","journal-title":"J Biol Chem"},{"issue":"25","key":"10.1016\/j.cpet.2009.12.008_bib107","doi-asserted-by":"crossref","first-page":"23599","DOI":"10.1074\/jbc.M501285200","article-title":"Delineation of positron emission tomography imaging agent binding sites on beta-amyloid peptide fibrils","volume":"280","author":"Ye","year":"2005","journal-title":"J Biol Chem"},{"issue":"46","key":"10.1016\/j.cpet.2009.12.008_bib108","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","article-title":"Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain","volume":"25","author":"Klunk","year":"2005","journal-title":"J Neurosci"},{"issue":"41","key":"10.1016\/j.cpet.2009.12.008_bib109","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","article-title":"Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography","volume":"27","author":"Maeda","year":"2007","journal-title":"J Neurosci"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib110","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2967\/jnumed.108.057984","article-title":"Characterization of PiB binding to white matter in Alzheimer disease and other dementias","volume":"50","author":"Fodero-Tavoletti","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2009.12.008_bib111","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0076-6879(99)09020-5","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T","volume":"309","author":"LeVine","year":"1999","journal-title":"Meth Enzymol"},{"issue":"Pt 10","key":"10.1016\/j.cpet.2009.12.008_bib112","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","article-title":"PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis","volume":"130","author":"Lockhart","year":"2007","journal-title":"Brain"},{"issue":"39","key":"10.1016\/j.cpet.2009.12.008_bib113","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","article-title":"In vitro characterization of Pittsburgh compound-B binding to Lewy bodies","volume":"27","author":"Fodero-Tavoletti","year":"2007","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib114","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1471-4159.2008.05245.x","article-title":"In vitro high affinity alpha-synuclein binding sites for the amyloid imaging agent PIB are not matched by binding to Lewy bodies in postmortem human brain","volume":"105","author":"Ye","year":"2008","journal-title":"J Neurochem"},{"issue":"Pt 6","key":"10.1016\/j.cpet.2009.12.008_bib115","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib116","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0197-4580(02)00123-9","article-title":"Emerging Alzheimer's disease therapies: focusing on the future","volume":"23","author":"Trojanowski","year":"2002","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"10.1016\/j.cpet.2009.12.008_bib117","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2004.08.004","article-title":"Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease","volume":"1025","author":"Kung","year":"2004","journal-title":"Brain Res"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib118","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1523\/JNEUROSCI.4456-03.2004","article-title":"Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain","volume":"24","author":"Okamura","year":"2004","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib119","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13645700600836000","article-title":"Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease","volume":"15","author":"Kudo","year":"2006","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"10.1016\/j.cpet.2009.12.008_bib120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.06.042","article-title":"In vitro characterisation of BF227 binding to alpha-synuclein\/Lewy bodies","volume":"617","author":"Fodero-Tavoletti","year":"2009","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib121","doi-asserted-by":"crossref","first-page":"T383","DOI":"10.1016\/j.jalz.2008.05.1129","article-title":"PET imaging of brain Amyloid deposits using BF-227 and its derivative [abstract]","volume":"4","author":"Okamura","year":"2008","journal-title":"Alzheimers Dement"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib122","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1471-4159.2008.05861.x","article-title":"AZD2184: a radioligand for sensitive detection of beta-amyloid deposits","volume":"108","author":"Johnson","year":"2009","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib123","first-page":"65P","article-title":"In vivo and in vitro labeling of plaques and tangles in the brain of an Alzheimer's disease patient: a case study","volume":"42","author":"Agdeppa","year":"2001","journal-title":"J Nucl Med"},{"issue":"24","key":"10.1016\/j.cpet.2009.12.008_bib124","doi-asserted-by":"crossref","first-page":"RC189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","article-title":"Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease","volume":"21","author":"Agdeppa","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.cpet.2009.12.008_bib125","first-page":"S194","article-title":"PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe","volume":"42","author":"Barrio","year":"1999","journal-title":"J Labelled Compd Radiopharm"},{"issue":"22","key":"10.1016\/j.cpet.2009.12.008_bib126","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1523\/JNEUROSCI.23-22-08029.2003","article-title":"Molecular-imaging probe 2-(1-[6-[(2-fluoroethyl)(methyl) amino]-2-naphthyl]ethylidene) malononitrile labels prion plaques in vitro","volume":"23","author":"Bresjanac","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib127","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1385\/JMN:19:3:321","article-title":"In vivo brain imaging of tangle burden in humans","volume":"19","author":"Small","year":"2002","journal-title":"J Mol Neurosci"},{"issue":"25","key":"10.1016\/j.cpet.2009.12.008_bib128","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1056\/NEJMoa054625","article-title":"PET of brain amyloid and tau in mild cognitive impairment","volume":"355","author":"Small","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib129","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/syn.20508","article-title":"Amyloid imaging in aged and young macaques with [11C]PIB and [18F]FDDNP","volume":"62","author":"Noda","year":"2008","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib130","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2967\/jnumed.108.056499","article-title":"Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET","volume":"50","author":"Tolboom","year":"2009","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib131","first-page":"1484","article-title":"Iodine-123 HIPDM brain imaging findings in subacute spongiform encephalopathy (Creutzfeldt-Jakob disease)","volume":"28","author":"Shih","year":"1987","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib132","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","article-title":"Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies","volume":"109","author":"Thompson","year":"2009","journal-title":"J Neurochem"},{"issue":"19","key":"10.1016\/j.cpet.2009.12.008_bib133","doi-asserted-by":"crossref","first-page":"5980","DOI":"10.1021\/jm050166g","article-title":"F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain","volume":"48","author":"Zhang","year":"2005","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib134","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","article-title":"F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain","volume":"32","author":"Zhang","year":"2005","journal-title":"Nucl Med Biol"},{"issue":"4\u00a0Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib135","doi-asserted-by":"crossref","first-page":"P77","DOI":"10.1016\/j.jalz.2009.05.189","article-title":"Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with Alzheimer's: Phase II results from a florpiramine F18 PET imaging study","volume":"5","author":"Doraiswamy","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"4\u00a0Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib136","doi-asserted-by":"crossref","first-page":"P197","DOI":"10.1016\/j.jalz.2009.04.088","volume":"5","author":"Sperling","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib137","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bmcl.2008.12.069","article-title":"Synthesis of 18F-labelled 2-(4\u2032-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [11C]PIB","volume":"19","author":"Serdons","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"4 Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib138","doi-asserted-by":"crossref","first-page":"P262","DOI":"10.1016\/j.jalz.2009.04.316","article-title":"Pharmacologic and pharmacokinetic equivalence studies of GE-067 to PiB [abstract]","volume":"5","author":"Mathis","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"4 Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib139","doi-asserted-by":"crossref","first-page":"P263","DOI":"10.1016\/j.jalz.2009.04.320","article-title":"Correlation between 18F-GE-067 and 11C-PIB uptake in Alzheimer's disease and MCI [abstract]","volume":"5","author":"Van Laere","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"4 Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib140","doi-asserted-by":"crossref","first-page":"P267","DOI":"10.1016\/j.jalz.2009.04.332","article-title":"AZD4694: fluorinated positron emission tomography (PET) radioligand for detection of beta-amyloid deposits [abstract]","volume":"5","author":"Sundgren-Andersson","year":"2009","journal-title":"Alzheimers Dement"},{"issue":"20","key":"10.1016\/j.cpet.2009.12.008_bib141","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib142","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","article-title":"PET imaging of amyloid deposition in patients with mild cognitive impairment","volume":"29","author":"Forsberg","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib143","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib144","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","article-title":"Imaging amyloid deposition in Lewy body diseases","volume":"71","author":"Gomperts","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2008.12.008","article-title":"Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics","volume":"34","author":"Maetzler","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib146","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib147","first-page":"309","article-title":"Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease","volume":"135","author":"Joachim","year":"1989","journal-title":"Am J Pathol"},{"issue":"23","key":"10.1016\/j.cpet.2009.12.008_bib148","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"J Neurosci"},{"issue":"Pt 7","key":"10.1016\/j.cpet.2009.12.008_bib149","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/brain\/awn107","article-title":"PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease","volume":"131","author":"Koivunen","year":"2008","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1212\/01.wnl.0000265815.38958.b6","article-title":"Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease","volume":"69","author":"Boxer","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cpet.2009.12.008_bib151","first-page":"1537","article-title":"11C-PiB PET studies in typical sporadic Creutzfeldt-Jakob disease","volume":"66","author":"Villemagne","year":"2009","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib152","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.parkreldis.2007.07.010","article-title":"[(11)C]-PIB imaging in patients with Parkinson's disease: preliminary results","volume":"14","author":"Johansson","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib153","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","article-title":"Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography","volume":"79","author":"Edison","year":"2008","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib154","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","article-title":"[11C]PIB binding in Parkinson's disease dementia","volume":"39","author":"Maetzler","year":"2008","journal-title":"Neuroimage"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib155","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archneur.64.8.1140","article-title":"Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B","volume":"64","author":"Ng","year":"2007","journal-title":"Arch Neurol"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib156","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.cpet.2009.12.008_bib157","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib158","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archneur.64.3.431","article-title":"Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report","volume":"64","author":"Bacskai","year":"2007","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib159","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0197-4580(00)00173-1","article-title":"Quantitative neurohistological features of frontotemporal degeneration","volume":"21","author":"Arnold","year":"2000","journal-title":"Neurobiol Aging"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib160","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","article-title":"Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B","volume":"65","author":"Leinonen","year":"2008","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib161","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.21164","article-title":"Imaging of amyloid burden and distribution in cerebral amyloid angiopathy","volume":"62","author":"Johnson","year":"2007","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib162","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","article-title":"Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease","volume":"39","author":"Drzezga","year":"2008","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib163","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","article-title":"In vivo amyloid imaging with PET in frontotemporal dementia","volume":"35","author":"Engler","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"15","key":"10.1016\/j.cpet.2009.12.008_bib164","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","article-title":"11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration","volume":"68","author":"Rabinovici","year":"2007","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21451","article-title":"Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia","volume":"64","author":"Rabinovici","year":"2008","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib166","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archneur.58.3.397","article-title":"Mild cognitive impairment represents early-stage Alzheimer disease","volume":"58","author":"Morris","year":"2001","journal-title":"Arch Neurol"},{"issue":"19","key":"10.1016\/j.cpet.2009.12.008_bib167","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000260969.94695.56","article-title":"PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment","volume":"68","author":"Kemppainen","year":"2007","journal-title":"Neurology"},{"issue":"Pt 11","key":"10.1016\/j.cpet.2009.12.008_bib168","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.cpet.2009.12.008_bib169","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","article-title":"Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease","volume":"46","author":"Villemagne","year":"2008","journal-title":"Neuropsychologia"},{"issue":"11","key":"10.1016\/j.cpet.2009.12.008_bib170","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","article-title":"Frequent amyloid deposition without significant cognitive impairment among the elderly","volume":"65","author":"Aizenstein","year":"2008","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.cpet.2009.12.008_bib171","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/WNL.38.11.1688","article-title":"A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques","volume":"38","author":"Davies","year":"1988","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib172","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1212\/01.wnl.0000256373.39415.b1","article-title":"Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis","volume":"68","author":"Forman","year":"2007","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib173","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/JMN:17:2:101","article-title":"Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease","volume":"17","author":"Morris","year":"2001","journal-title":"J Mol Neurosci"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib174","first-page":"1075","article-title":"The neuropathological changes associated with normal brain aging","volume":"11","author":"Hof","year":"1996","journal-title":"Histol Histopathol"},{"issue":"23","key":"10.1016\/j.cpet.2009.12.008_bib175","doi-asserted-by":"crossref","first-page":"pe26","DOI":"10.1126\/sageke.2004.23.pe26","article-title":"Neurodegeneration in normal brain aging and disease","volume":"2004","author":"Thal","year":"2004","journal-title":"Sci Aging Knowledge Environ"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib176","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1037\/0894-4105.19.4.520","article-title":"Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis","volume":"19","author":"Backman","year":"2005","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib177","first-page":"19","article-title":"Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment","volume":"62","author":"Small","year":"2007","journal-title":"Geriatrics"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib178","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer's disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib179","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/WCO.0b013e3281a47744","article-title":"Amyloid imaging in Alzheimer's disease","volume":"20","author":"Nordberg","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.64.3.noc60123","article-title":"Cerebrospinal fluid tau\/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults","volume":"64","author":"Fagan","year":"2007","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib181","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.20730","article-title":"Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta(42) in humans","volume":"59","author":"Fagan","year":"2006","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib182","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000163927","article-title":"PET amyloid ligand [C]PIB uptake and cerebrospinal fluid beta-amyloid in mild cognitive impairment","volume":"26","author":"Koivunen","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib183","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.20889","article-title":"Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study","volume":"60","author":"Archer","year":"2006","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"10.1016\/j.cpet.2009.12.008_bib184","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain"},{"issue":"17","key":"10.1016\/j.cpet.2009.12.008_bib185","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1212\/WNL.0b013e3181a2e896","article-title":"In vivo mapping of amyloid toxicity in Alzheimer disease","volume":"72","author":"Frisoni","year":"2009","journal-title":"Neurology"},{"issue":"Pt 5","key":"10.1016\/j.cpet.2009.12.008_bib186","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib187","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","article-title":"Neuropathology of older persons without cognitive impairment from two community-based studies","volume":"66","author":"Bennett","year":"2006","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cpet.2009.12.008_bib188","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.cpet.2009.12.008_bib189","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2967\/jnumed.106.037762","article-title":"Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease","volume":"48","author":"Ng","year":"2007","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib191","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib192","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001854","article-title":"Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease","volume":"11","author":"Martins","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib193","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<695::AID-GPS19>3.0.CO;2-R","article-title":"The current status of apo E4 as a risk factor for Alzheimer's disease: an epidemiological perspective","volume":"14","author":"Ritchie","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"issue":"16","key":"10.1016\/j.cpet.2009.12.008_bib194","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib195","first-page":"216P","article-title":"Pattern of Abeta deposition in familial Alzheimer's disease is irrespective of mutation type or cognitive status [abstract]","volume":"49","author":"Villemagne","year":"2008","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib196","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ana.21598","article-title":"Amyloid imaging in mild cognitive impairment subtypes","volume":"65","author":"Wolk","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.cpet.2009.12.008_bib197","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","article-title":"Conversion of amyloid positive and negative MCI to AD over 3 years. An 11C-PIB PET study","volume":"73","author":"Okello","year":"2009","journal-title":"Neurology"},{"issue":"34","key":"10.1016\/j.cpet.2009.12.008_bib198","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","author":"Buckner","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.cpet.2009.12.008_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1440.011","article-title":"The brain's default network: anatomy, function, and relevance to disease","volume":"1124","author":"Buckner","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib200","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1007\/s00259-007-0698-5","article-title":"A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease","volume":"35","author":"Wermke","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Pt 11","key":"10.1016\/j.cpet.2009.12.008_bib201","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/brain\/awl178","article-title":"Two-year follow-up of amyloid deposition in patients with Alzheimer's disease","volume":"129","author":"Engler","year":"2006","journal-title":"Brain"},{"issue":"Pt 5","key":"10.1016\/j.cpet.2009.12.008_bib202","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib203","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib204","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","article-title":"The Alzheimer's disease neuroimaging initiative","volume":"15","author":"Mueller","year":"2005","journal-title":"Neuroimaging Clin N Am"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib205","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0006-2952(03)00534-3","article-title":"Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease","volume":"66","author":"Eckert","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib206","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1089\/ars.2007.1763","article-title":"Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease?","volume":"9","author":"Leuner","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"13","key":"10.1016\/j.cpet.2009.12.008_bib207","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1523\/JNEUROSCI.4856-03.2004","article-title":"Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early beta-amyloid accumulation","volume":"24","author":"Suo","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.cpet.2009.12.008_bib208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2007.01.071","article-title":"Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis","volume":"1143","author":"Resende","year":"2007","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib209","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(03)00381-6","article-title":"Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice","volume":"120","author":"Roder","year":"2003","journal-title":"Neuroscience"},{"issue":"Pt 11","key":"10.1016\/j.cpet.2009.12.008_bib210","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1093\/brain\/awl176","article-title":"Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology","volume":"129","author":"Capetillo-Zarate","year":"2006","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib211","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.21212","article-title":"Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease","volume":"63","author":"Kemppainen","year":"2008","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2009.12.008_bib212","first-page":"S50","article-title":"Brain reserve and the clinical expression of Alzheimer's disease","volume":"52","author":"Mortimer","year":"1997","journal-title":"Geriatrics"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib213","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1017\/S1355617702813248","article-title":"What is cognitive reserve? Theory and research application of the reserve concept","volume":"8","author":"Stern","year":"2002","journal-title":"J Int Neuropsychol Soc"},{"issue":"11","key":"10.1016\/j.cpet.2009.12.008_bib214","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/archneur.65.11.1467","article-title":"Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake","volume":"65","author":"Roe","year":"2008","journal-title":"Arch Neurol"},{"issue":"22","key":"10.1016\/j.cpet.2009.12.008_bib215","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1523\/JNEUROSCI.1189-06.2006","article-title":"Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons","volume":"26","author":"Deshpande","year":"2006","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib216","first-page":"5","article-title":"Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity?","volume":"49","author":"Walker","year":"2008","journal-title":"Rom J Morphol Embryol"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib217","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neurobiolaging.2008.05.026","article-title":"Molecular polymorphism of Abeta in Alzheimer's disease","volume":"31","author":"Levine","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib218","first-page":"542","article-title":"PIB binding in aged primate brain: Enrichment of high-affinity sites in humans with Alzheimer's disease","volume":"31","author":"Rosen","year":"2010","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib219","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000109754","article-title":"Biomarkers for early detection of Alzheimer pathology","volume":"16","author":"Clark","year":"2008","journal-title":"Neurosignals"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrd2176","article-title":"Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics","volume":"6","author":"Shaw","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib221","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000119457","article-title":"Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides","volume":"5","author":"Hoglund","year":"2008","journal-title":"Neurodegener Dis"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib222","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer's disease using the CSF Abeta42\/Abeta40 ratio in patients with mild cognitive impairment","volume":"23","author":"Hansson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib223","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib224","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1523\/JNEUROSCI.23-03-00994.2003","article-title":"Dynamics of gray matter loss in Alzheimer's disease","volume":"23","author":"Thompson","year":"2003","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0891988706291089","article-title":"Diagnostic issues in dementia: neuroimaging as a surrogate marker of disease","volume":"19","author":"Small","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"3","key":"10.1016\/j.cpet.2009.12.008_bib226","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2796.2004.01381.x","article-title":"MRI and CSF studies in the early diagnosis of Alzheimer's disease","volume":"256","author":"de Leon","year":"2004","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib227","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/156720506776383103","article-title":"Predictors of conversion to dementia of probable Alzheimer type in patients with mild cognitive impairment","volume":"3","author":"Modrego","year":"2006","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"10.1016\/j.cpet.2009.12.008_bib228","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneurol.2007.23","article-title":"Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia","volume":"65","author":"Smith","year":"2008","journal-title":"Arch Neurol"},{"issue":"15","key":"10.1016\/j.cpet.2009.12.008_bib229","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1212\/01.wnl.0000277458.26846.96","article-title":"Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment","volume":"69","author":"van de Pol","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.cpet.2009.12.008_bib230","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1212\/01.WNL.0000160089.43264.1A","article-title":"MRI predictors of risk of incident Alzheimer disease: a longitudinal study","volume":"64","author":"Stoub","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.cpet.2009.12.008_bib231","article-title":"Whole brain atrophy rate predicts progression from MCI to Alzheimer's disease","author":"Spulber","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib232","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.wnl.0000180958.22678.91","article-title":"Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI","volume":"65","author":"Jack","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib233","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1536-1632(02)00016-1","article-title":"Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment","volume":"4","author":"Silverman","year":"2002","journal-title":"Mol Imaging Biol"},{"issue":"12","key":"10.1016\/j.cpet.2009.12.008_bib234","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/jama.273.12.942","article-title":"Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease","volume":"273","author":"Small","year":"1995","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.cpet.2009.12.008_bib235","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","article-title":"Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome","volume":"286","author":"Silverman","year":"2001","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib236","first-page":"71P","article-title":"Prognostic value of regional brain metabolism in evaluation of dementia","volume":"40","author":"Silverman","year":"1999","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2009.12.008_bib237","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/14737159.4.1.63","article-title":"Accuracy of early diagnosis and its impact on the management and course of Alzheimer's disease","volume":"4","author":"Chang","year":"2004","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"10.1016\/j.cpet.2009.12.008_bib238","first-page":"253","article-title":"Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits","volume":"43","author":"Silverman","year":"2002","journal-title":"J Nucl Med"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib239","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","article-title":"Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study","volume":"30","author":"Drzezga","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.cpet.2009.12.008_bib240","first-page":"1625","article-title":"Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET","volume":"46","author":"Drzezga","year":"2005","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2009.12.008_bib241","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0197-4580(03)00002-2","article-title":"Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease","volume":"24","author":"Frank","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"8","key":"10.1016\/j.cpet.2009.12.008_bib242","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S1474-4422(06)70503-8","article-title":"Plasma Abeta in Alzheimer's disease\u2014up or down?","volume":"5","author":"Zetterberg","year":"2006","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2009.12.008_bib243","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1007\/s00259-007-0708-7","article-title":"Smart optical probes for near-infrared fluorescence imaging of Alzheimer's disease pathology","volume":"35","author":"Raymond","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.cpet.2009.12.008_bib244","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nbt1085","article-title":"In vivo detection of amyloid-beta deposits by near-infrared imaging using an oxazine-derivative probe","volume":"23","author":"Hintersteiner","year":"2005","journal-title":"Nat Biotechnol"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859809001734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859809001734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:57:26Z","timestamp":1740128246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859809001734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":244,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1556859809001734"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2009.12.008","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}